Acquirer Profile
Neurocrine Biosciences Acquisitions & Deals (2026)
Biotechnology
Deals tracked
1
Combined value
$2.9B
Primary sector
Biotechnology
Active
2026
FireStrike tracks every Neurocrine Biosciences acquisition, merger, and strategic investment in real time. This page covers 1 Neurocrine Biosciences deals totaling $2.9B in disclosed deal value, spanning Biotechnology. Data covers 2026.
Neurocrine Biosciences Acquisitions — Full List
| Target company | Announced | Source |
|---|---|---|
Soleno Therapeutics Biotechnology | Apr 2026 |
Neurocrine Biosciences Acquisitions — FAQ
How many acquisitions has Neurocrine Biosciences made?
Neurocrine Biosciences has made 1 acquisitions and deals tracked on FireStrike, totaling $2.9B in combined deal value.
What sectors does Neurocrine Biosciences acquire in?
Neurocrine Biosciences primarily acquires in Biotechnology.
What is Neurocrine Biosciences's most recent acquisition?
Neurocrine Biosciences's most recent tracked acquisition is Soleno Therapeutics for $2.9B, announced Apr 2026.
Get every Neurocrine Biosciences deal in your inbox
FireStrike tracks M&A, IPOs, and fundraises daily — free.
Start tracking free →